Shoreline Biosciences

0 followers


Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.

Industries

Headquarters

Stage

Employees

Links

Org chart

Kleanthis G. Xanthopoulos

Collapse
Robert Hollingsworth
Chief Scientific Officer
Scott Forrest
Chief Business Officer
Mauro P. Avanzi
Chief Medical Officer
Steven Neben
VP, Alliance & Project Management
Paschalis Sideras
VP, Discovery Immunobiology
Krishna Patel
HR Manager